The CD8+T cells response is sufficient for protection with a CCHFV M-segment based DNA vaccine and GP38 enhances vaccine immunogenicity

Introduction: Crimean-Congo hemorrhagic fever virus (CCHFV) is the most widely distributed tick-borne virus of human medical importance, with outbreaks occurring in the Middle East, Asia, Africa, and parts of Western Europe. Our team developed and tested a DNA vaccine expressing the full-length codo...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:International Journal of Infectious Diseases
المؤلفون الرئيسيون: Dr. Joseph Golden, Collin Fitzpatrick, Dr John Suschak, Tamara Clements, Dr. Keersten Ricks, Mariano Sanchez-Lockhart, Dr Aura Garrison
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Elsevier 2025-03-01
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S1201971224008099